Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase
Franz L. Knörnschild,Sven Liebig,Peggy Kießling,Monika Prpic,Tehyung Kim,Ulrich Keller,Kai Kappert,Stefan Schwartz,Amir Jahic
DOI: https://doi.org/10.1515/cclm-2024-0523
2024-07-13
Clinical Chemistry and Laboratory Medicine (CCLM)
Abstract:Funding source: SERB SAS Award Identifier / Grant number: Honoraria Funding source: Protherics Medicines Development Ltd. Award Identifier / Grant number: Research Grant Sebastian Kühn (Labor Berlin – Charité Vivantes Services GmbH) is acknowledged for excellent technical support. The authors are grateful to all patients who participated in this study. We thank Dr. Katharina Friedrich, Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité – Universitätsmedizin Berlin, for her support in formatting the manuscript and critical input for result interpretation. FLK is MD candidate at Charité – Universitätsmedizin Berlin. This work is submitted in fulfillment of the requirement for the medical dissertation. Research ethics: This study was approved by the Ethics Committee of the Charité – Universitätsmedizin Berlin (ref. No. EA4/258/21) and was conducted in accordance with the Declaration of Helsinki (as revised in 2013). Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards. Author contributions: FLK, SL, SS, AJ, UK, and KK contributed to the conception and design of the study, acquisition of data, data analysis and interpretation, and revised the article critically. PK, MP, IM and TK performed acquisition of data and data analysis. FLK, SS and AJ drafted the article, and revised the article critically for important intellectual content. The authors have accepted responsibility for the entire content of this manuscript and approved its submission. Competing interests: Stefan Schwartz has received honoraria from SERB SAS and a research grant from Protherics Medicines Development Ltd for the present study. All other authors declare no competing financial interests. Research funding: Stefan Schwartz has received honoraria from SERB SAS and a research grant from Protherics Medicines Development Ltd for the present study. Data availability: The raw data can be obtained on request from the corresponding author. Trial registration: This study is registered at ClinicalTrials.gov: NCT05250869. 1. Widemann, BC, Adamson, PC. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006;11:694–703. https://doi.org/10.1634/theoncologist.11-6-694. Search in Google Scholar PubMed 2. Garneau, AP, Riopel, J, Isenring, P. Acute methotrexate-induced crystal nephropathy. N Engl J Med 2015;373:2691–3. https://doi.org/10.1056/nejmc1507547. Search in Google Scholar PubMed 3. Sherwood, RF, Melton, RG, Alwan, SM, Hughes, P. Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method. Eur J Biochem 1985;148:447–53. https://doi.org/10.1111/j.1432-1033.1985.tb08860.x. Search in Google Scholar PubMed 4. Schwartz, S, Borner, K, Muller, K, Martus, P, Fischer, L, Korfel, A, et al.. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy. Oncologist 2007;12:1299–308. https://doi.org/10.1634/theoncologist.12-11-1299. Search in Google Scholar PubMed 5. Widemann, BC, Balis, FM, Kim, A, Boron, M, Jayaprakash, N, Shalabi, A, et al.. Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome. J Clin Oncol 2010;28:3979–86. https://doi.org/10.1200/jco.2009.25.4540. Search in Google Scholar 6. Widemann, BC, Sung, E, Anderson, L, Salzer, WL, Balis, FM, Monitjo, KS, et al.. Pharmacokinetics and metabolism of the methotrexate metabolite 2,4-diamino-N(10)-methylpteroic acid. J Pharmacol Exp Ther 2000;294:894–901. Search in Google Scholar 7. Widemann, BC, Balis, FM, Murphy, RF, Sorensen, JM, Montello, MJ, O'Brien, M, et al.. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients -Abstract Truncated-
medical laboratory technology